Gilead Sciences
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404
Phone: (650) 574-3000Website: https://www.gilead.com/Careers: www.gilead.com/careersPatient Assistance Program: www.gilead.com/purpose/medication-access
Latest news
- FDA Approves Yeztugo (lenacapavir) as the First and Only HIV Prevention Option Offering 6 Months of Protection
18 June 2025 - Final Data From the Phase 3 MYR301 Study Demonstrated Longer Treatment With Bulevirtide Was Associated With Sustaining Undetectability After Stopping Treatment
7 May 2025 - U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review
18 February 2025 - Gilead Announces Plans to Voluntarily Withdraw the U.S. Accelerated Approval for Trodelvy in Metastatic Urothelial Cancer
18 October 2024 - FDA Grants Accelerated Approval for Livdelzi (seladelpar) for the Treatment of Primary Biliary Cholangitis
14 August 2024 - Gilead Announces New England Journal of Medicine Publication of Data that Demonstrate Bulevirtide with PegIFN Achieved Post-Treatment Undetectable HDV RNA
6 June 2024 - Gilead’s Seladelpar Demonstrated a Sustained and Consistent Long-Term Efficacy and Safety Profile in Primary Biliary Cholangitis
5 June 2024 - Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
18 May 2024 - FDA Approves Biktarvy Label Update With Data for Pregnant Adults With HIV
26 April 2024 - FDA Expands Indication for Gilead's Vemlidy (tenofovir alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six
28 March 2024
Drugs Associated with Gilead Sciences, Inc.
Gilead Sciences, Inc. manufactures, markets and/or distributes more than 27 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
AmBisome
Generic name: amphotericin b liposomal Drug class: polyenes |
||
|
Biktarvy
Generic name: bictegravir/emtricitabine/tenofovir alafenamide Drug class: antiviral combinations |
220 reviews | 7.2 / 10 |
|
Cayston
Generic name: aztreonam Drug class: monobactams |
||
|
Complera
Generic name: emtricitabine/rilpivirine/tenofovir disoproxil Drug class: antiviral combinations |
60 reviews | 8.3 / 10 |
|
Descovy
Generic name: emtricitabine/tenofovir alafenamide Drug class: antiviral combinations |
22 reviews | 7.4 / 10 |
|
Emtriva
Generic name: emtricitabine Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) |
||
|
Epclusa
Generic name: sofosbuvir/velpatasvir Drug class: antiviral combinations |
397 reviews | 7.6 / 10 |
|
Genvoya
Generic name: cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide Drug class: antiviral combinations |
129 reviews | 7.2 / 10 |
|
Harvoni
Generic name: ledipasvir/sofosbuvir Drug class: antiviral combinations |
403 reviews | 8.4 / 10 |
|
Hepsera
Generic name: adefovir Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) |
||
|
Letairis
Generic name: ambrisentan Drug class: agents for pulmonary hypertension |
12 reviews | 8.2 / 10 |
|
Livdelzi
Generic name: seladelpar Drug class: miscellaneous metabolic agents |
||
|
Odefsey
Generic name: emtricitabine/rilpivirine/tenofovir alafenamide Drug class: antiviral combinations |
10 reviews | 8.4 / 10 |
|
Sovaldi
Generic name: sofosbuvir Drug class: miscellaneous antivirals |
47 reviews | 7.6 / 10 |
|
Stribild
Generic name: cobicistat/elvitegravir/emtricitabine/tenofovir disoproxil Drug class: antiviral combinations |
88 reviews | 9.5 / 10 |
|
Sunlenca
Generic name: lenacapavir Drug class: miscellaneous antivirals |
2 reviews | 8.5 / 10 |
|
Tecartus
Generic name: brexucabtagene autoleucel Drug class: miscellaneous antineoplastics |
||
|
Trodelvy
Generic name: sacituzumab govitecan Drug class: miscellaneous antineoplastics |
4 reviews | 6.8 / 10 |
|
Truvada
Generic name: emtricitabine/tenofovir disoproxil Drug class: antiviral combinations |
40 reviews | 6.2 / 10 |
|
Tybost
Generic name: cobicistat Drug class: antiviral boosters |
||
|
Veklury
Generic name: remdesivir Drug class: purine nucleosides |
||
|
Vemlidy
Generic name: tenofovir alafenamide Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) |
1 review | 8.0 / 10 |
|
Viread
Generic name: tenofovir disoproxil Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) |
13 reviews | 7.7 / 10 |
|
Vosevi
Generic name: sofosbuvir/velpatasvir/voxilaprevir Drug class: antiviral combinations |
2 reviews | 10 / 10 |
|
Yescarta
Generic name: axicabtagene ciloleucel Drug class: miscellaneous antineoplastics |
||
|
Yeztugo
Generic name: lenacapavir Drug class: miscellaneous antivirals |
||
|
Zydelig
Generic name: idelalisib Drug class: PI3K inhibitors |
2 reviews | 4.5 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
Discontinued Drugs
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Atripla
Generic name: efavirenz/emtricitabine/tenofovir disoproxil Drug class: antiviral combinations |
105 reviews | 9.0 / 10 |
|
Vistide
Generic name: cidofovir Drug class: purine nucleosides |
||
|
Vitekta
Generic name: elvitegravir Drug class: integrase strand transfer inhibitor |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||